Table 3 Cardiovascular risk factors and aspirin use among examination subgroup free of disease
N = 184 | |
|---|---|
Age, median (IQR) | 59.5 (51–67.5) |
Male, n (%) | 78 (42.4%) |
White, non-hispanic, n (%) | 161 (87.5%) |
Black, non-hispanic, n (%) | 8 (4.4%) |
Hispanic, n (%) | 15 (8.2%) |
Community sample, n (%) | 137 (74.5%) |
Health facility sample, n (%) | 47 (25.5%) |
Weight, kg, median (IQR) | 79.8 (66.7-92.1) |
BMI, kg m2, median (IQR) | 26.4 (23.6-30.7) |
SBP, mmHg, median (IQR) | 118 (111–123) |
DBP, mmHg, median (IQR) | 68 (61–75) |
LDL, median (IQR) | 105 (81–129) |
HDL, median (IQR) | 62 (47–74) |
Triglycerides, median (IQR) | 117 (84–171) |
Current or recent (<1 yr) tobacco smoker, n (%) | 16 (8.7%) |
Told you have diabetes by health professional, n (%) | 27 (14.8%) |
Hgb A1C >6.5% or using an oral hypoglycemic medication, n (%) | 24 (13.1%) |
Ten-year CHD Risk <10%, n (%) | 160 (87.0%) |
Ten-year CHD Risk ≥10%, n (%) | 24 (13.1%) |
Routine aspirin use | 66 (35.9%) |
Risks and benefits of aspirin to prevent heart attack or stroke | |
ever discussed with you | 92 (50.0%) |
Health problem that make aspirin or NSAIDs unsafe | 21 (11.4%) |